IndiMag

WIPO WIPO 2019

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark IndiMag was filed as Word mark on 01/24/2019 at the World Intellectual Property Organization.

Trademark Details Last update: January 7, 2022

Trademark form Word mark
File reference 1472576
Countries Australia Switzerland China India Japan South Korea Singapore United States of America (USA)
Base trademark EU No. 017934152, July 24, 2018
Application date January 24, 2019
Expiration date January 24, 2029

Trademark owner

Deutscher Platz 5b
04103 Leipzig
DE

Trademark representatives

Fasanenstr. 29 10719 Berlin DE

goods and services

01 Chemical, biochemical and biotechnological products for industrial and scientific purposes and laboratory analysis, reagents and solvents for sample preparation, modification and manipulation of cells as well as for labelling, separation, isolation, purification, amplification and/or analysis of natural or synthetic biopolymers, namely nucleic acids, oligonucleotides, proteins, macromolecules and biologically active substances; chemicals or biochemical products used in industry, in particular substances for molecular biological, biochemical and immunological testing and analysis; kits comprising chemical products for sample preparation, modification and manipulation of samples and cells as well as for labelling, separation, isolation, purification, amplification and/or analysis of natural or synthetic biopolymers, namely nucleic acids, oligonucleotides, proteins, macromolecules and biologically active substances, namely nucleic acids from biological or biochemical sample material, included in this class
05 Pharmaceutical and veterinary medical products as well as products for healthcare purposes, diagnostic preparations for medical and veterinary purposes; diagnostic agents for medical, veterinary, laboratory medical and forensic purposes, including agents for in-vitro diagnostics; diagnostic agents for medical and veterinary purposes, namely biological and preparations for testing diseases in cattle, pigs, and other animals; diagnostic preparations for medical and veterinary purposes; reagents, oligonucleotides, antibodies, in-vitro diagnostics and control reagents for medical purposes, being kit components; testing equipment for sale in kit form, for medical, veterinary, dental, legal medical, laboratory medical and forensic purposes; products for medical and veterinary medical purposes, namely diagnostic preparations, namely for sample preparation, modification and manipulation of cells as well as for labelling, separation, isolation, purification, amplification and/or analysis of natural or synthetic biopolymers, namely nucleic acids, oligonucleotides, proteins, macromolecules and biologically active substances; chemical, biochemical and biotechnological products, namely reagents and solvents for sample preparation, modification and manipulation of cells; in vitro diagnostic preparations for medical purposes; kits comprising products for medical and veterinary medical diagnostic purposes (terms considered too vague in the opinion of the International Bureau – Rule 13 (2) (b) of the Common Regulations); kits, containing reagents, oligonucleotides, antibodies, in-vitro diagnostic preparations, control reagents for medical or veterinary use; test strips for medical use
09 Molecular biological and immunological test systems (terms considered too vague in the opinion of the International Bureau – Rule 13 (2) (b) of the Common Regulations), kits for multiplex PCR tests containing at least of the following components, devices for removing, marking, applying and identifying biological or biochemical samples, sequencing apparatus, PCR cyclers, including associated hardware and software (terms considered too vague in the opinion of the International Bureau – Rule 13 (2) (b) of the Common Regulations); scientific apparatus and instruments; apparatus and instruments for scientific research in laboratories; molecular biological and immunological testing systems (terms considered too vague in the opinion of the International Bureau – Rule 13 (2) (b) of the Common Regulations), kits for multiplex PCR tests, including hardware and software therefor; electronic or online manuals and/or instruments for biochemical, molecular biological and immunological testing sold in a kit
10 Surgical, medical, dental and veterinary apparatus and instruments; medical apparatus, instruments and articles; samples and apparatus for testing and analyzing biological material (terms considered too vague in the opinion of the International Bureau – Rule 13 (2) (b) of the Common Regulations)
42 Molecular biological, biochemical and immunological analysis; conducting molecular biological, biochemical and immunological analysis for testing diseases in cattle, pigs and other animals; scientific and technological services and research; scientific research for medical purposes; services for screening personal samples for antibodies or antigens (terms considered too vague in the opinion of the International Bureau – Rule 13 (2) (b) of the Common Regulations); services for detecting or measuring selected antibodies or antigens in personal samples; laboratory services relating to the production of monoclonal or polyclonal antibodies; medical scientific research, including biological research and especially research into human monoclonal antibodies and development of pharmaceutical products based on human monoclonal antibodies
44 Information services relating to veterinary pharmaceuticals; providing information relating to veterinary services; veterinary services (professional consultancy relating to -); laboratory analysis services relating to the treatment of animals

Trademark history

Date Document number Area Entry
January 4, 2022 2022/1 Gaz US Rejection
August 19, 2021 2021/34 Gaz KR RAW: Rule 18ter(2)(ii) GP following a provisional refusal
April 15, 2021 2021/16 Gaz JP RAW: Rule 18ter(2)(ii) GP following a provisional refusal
February 3, 2021 2021/7 Gaz CH RAW: Rule 18ter(2)(ii) GP following a provisional refusal
January 17, 2021 2021/4 Gaz SG RAW: Rule 18ter(2)(ii) GP following a provisional refusal
September 25, 2020 2020/40 Gaz KR Rejection
August 13, 2020 2020/34 Gaz JP Rejection
July 30, 2020 2020/40 Gaz EM RAW: Partial Ceasing Effect
June 3, 2020 2020/24 Gaz AU RAW: Rule 18ter(2)(ii) GP following a provisional refusal
May 22, 2020 2020/23 Gaz CH Rejection
March 12, 2020 2020/11 Gaz KR Rejection
December 2, 2019 2019/49 Gaz IN Rejection
October 17, 2019 2019/43 Gaz AU Rejection
September 7, 2019 2019/37 Gaz SG Rejection
August 26, 2019 2019/35 Gaz CN Rejection
July 19, 2019 2019/30 Gaz US Rejection
January 24, 2019 2019/23 Gaz EM Registration

ID: 141472576